[38] demonstrated that the YAP inhibitor verteporfin significantly lowered CTGF and TGF-β levels in the renal tubulointerstitial and alleviated renal fibrosis due to unilateral ureteral obstruction (UUO). Here, CCN2 is linked to renal fibrosis.